Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02518958
Title A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors EpicentRx, Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.